Neurologic aspects of giant cell (temporal) arteritis

Richard John Caselli, G. G. Hunder

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Headache is the most frequent symptom for which a patient with giant cell arteritis (GCA) presents to a neurologist. Amaurosis fugax and ischemic optic neuropathy are well-recognized complications. Less commonly recognized neurologic complications include transient ischemic attacks, cerebral infarctions, acute confusional states (due to multi-infarct dementia), ischemic cervical myelopathy, and ischemic mononeuropathies. Because patients with GCA generally respond well to corticosteroid therapy, prompt diagnosis can minimize neurologic damage.

Original languageEnglish (US)
Pages (from-to)941-953
Number of pages13
JournalRheumatic Disease Clinics of North America
Volume19
Issue number4
StatePublished - 1993

Fingerprint

Giant Cell Arteritis
Nervous System
Amaurosis Fugax
Multi-Infarct Dementia
Spinal Cord Ischemia
Mononeuropathies
Ischemic Optic Neuropathy
Confusion
Transient Ischemic Attack
Cerebral Infarction
Headache
Adrenal Cortex Hormones
Therapeutics
Neurologists

ASJC Scopus subject areas

  • Rheumatology

Cite this

Neurologic aspects of giant cell (temporal) arteritis. / Caselli, Richard John; Hunder, G. G.

In: Rheumatic Disease Clinics of North America, Vol. 19, No. 4, 1993, p. 941-953.

Research output: Contribution to journalArticle

@article{518b76c56be245789100ad0ae9742df9,
title = "Neurologic aspects of giant cell (temporal) arteritis",
abstract = "Headache is the most frequent symptom for which a patient with giant cell arteritis (GCA) presents to a neurologist. Amaurosis fugax and ischemic optic neuropathy are well-recognized complications. Less commonly recognized neurologic complications include transient ischemic attacks, cerebral infarctions, acute confusional states (due to multi-infarct dementia), ischemic cervical myelopathy, and ischemic mononeuropathies. Because patients with GCA generally respond well to corticosteroid therapy, prompt diagnosis can minimize neurologic damage.",
author = "Caselli, {Richard John} and Hunder, {G. G.}",
year = "1993",
language = "English (US)",
volume = "19",
pages = "941--953",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Neurologic aspects of giant cell (temporal) arteritis

AU - Caselli, Richard John

AU - Hunder, G. G.

PY - 1993

Y1 - 1993

N2 - Headache is the most frequent symptom for which a patient with giant cell arteritis (GCA) presents to a neurologist. Amaurosis fugax and ischemic optic neuropathy are well-recognized complications. Less commonly recognized neurologic complications include transient ischemic attacks, cerebral infarctions, acute confusional states (due to multi-infarct dementia), ischemic cervical myelopathy, and ischemic mononeuropathies. Because patients with GCA generally respond well to corticosteroid therapy, prompt diagnosis can minimize neurologic damage.

AB - Headache is the most frequent symptom for which a patient with giant cell arteritis (GCA) presents to a neurologist. Amaurosis fugax and ischemic optic neuropathy are well-recognized complications. Less commonly recognized neurologic complications include transient ischemic attacks, cerebral infarctions, acute confusional states (due to multi-infarct dementia), ischemic cervical myelopathy, and ischemic mononeuropathies. Because patients with GCA generally respond well to corticosteroid therapy, prompt diagnosis can minimize neurologic damage.

UR - http://www.scopus.com/inward/record.url?scp=0027378155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027378155&partnerID=8YFLogxK

M3 - Article

C2 - 8265830

AN - SCOPUS:0027378155

VL - 19

SP - 941

EP - 953

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 4

ER -